Pfizer adds another $325M to Neurontin settlement tally. Total.
Jun 2, 2014. Pfizer $PFE agreed to pay $325 million to wrap up claims that its Parke-Davis unit touted the epilepsy drug Neurontin for uses not approved. For Health Care Professionals NEURONTIN U. S. Physician Prescribing Information · NEURONTIN U. S. Medical Information Page - clinical & safety information. Jun 2, 2014. Pfizer Inc has agreed to pay $325 million to resolve claims it defrauded insurers and other healthcare benefit providers by marketing Neurontin.
NEURONTIN® Pfizer One of the world's premier.
Jun 2, 2014. Pfizer Inc. agreed to pay $325 million to settle a lawsuit brought by health-care benefit providers who claimed the drugmaker marketed the. Oct 26, 2006. A lawsuit initiated by Dr. David Franklin, a whistleblower, has been settled Pfizer pleaded guilty to criminal fraud in the promotion of Neurontin. Oct 7, 2008. After it paid $430 million to settle a 2004 lawsuit over illegal promotion of its anti- seizure drug Neurontin, Pfizer, the world's largest.
Pfizer to pay $325 million in Neurontin settlement - Reuters
According to the San Francisco Chronicle, off-label prescriptions accounted for roughly 90 percent of Neurontin sales. Jun 6, 2014. Manufacturers of Neurontin reached a $325 million class action lawsuit settlement Wednesday over allegations they fraudulently marketed the.
Huge penalty in drug fraud / Pfizer settles felony case in Neurontin.
May 14, 2004. A division of Pfizer Inc. the world's largest drugmaker, has agreed to plead guilty to two felonies and pay $430 million in penalties to settle. These highlights do not include all the information needed to use NEURONTIN safely and effectively. See full prescribing information for NEURONTIN.